UFP TECHNOLOGIES INC UFPT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
7/9
Piotroski F — financial health
6
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $602.8M | $68.3M | $170.4M | — | $423.9M |
| 2024 | $504.4M | $59.0M | $146.7M | $56.9M | $342.8M |
| 2023 | $400.1M | $44.9M | $112.2M | $30.8M | $286.1M |
| 2022 | $353.8M | $41.8M | $90.3M | $4.0M | $237.5M |
| 2021 | $206.3M | $15.9M | $51.1M | $8.9M | $194.4M |
| 2020 | $179.4M | $13.4M | $44.7M | $20.7M | $176.9M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| FELDMANN CYNTHIA L | director | 2026-06-12 | Option exercise | 1,200 | $43.95 |
| FELDMANN CYNTHIA L | director | 2026-06-12 | Sell | 1,100 | $239.19 |
| FELDMANN CYNTHIA L | director | 2026-06-12 | Sell | 100 | $240.40 |
| BAILLY R JEFFREY | Executive Chairman | 2026-06-05 | Grant | 1,787 | — |
| BAILLY R JEFFREY | Executive Chairman | 2026-06-05 | Tax withheld | 750 | $223.87 |
| Stafford Ryan K | SVP Human Resources | 2026-06-04 | Grant | 1,448 | — |
| LATAILLE RONALD J | Chief Financial Officer | 2026-06-04 | Grant | 4,454 | — |
| ROCK MITCHELL | President | 2026-06-04 | Grant | 2,895 | — |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6 (safe)
- Working capital / assets 0.193
- Retained earnings / assets 0.572
- EBIT / assets 0.141
- Equity / liabilities 1.833
Source: SEC EDGAR filings · CIK 0000914156 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.